Blood transcriptional signatures for tuberculosis testing
Open Access
- 13 March 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet. Respiratory Medicine
- Vol. 8 (4), 330-331
- https://doi.org/10.1016/s2213-2600(20)30045-x
Abstract
No abstract availableKeywords
Funding Information
- US National Institutes of Health (number D43 TW010559)
This publication has 8 references indexed in Scilit:
- Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy studyThe Lancet Respiratory Medicine, 2020
- Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose TuberculosisThe Journal of Infectious Diseases, 2019
- Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage TestsThe Journal of Infectious Diseases, 2019
- Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease statePLOS ONE, 2019
- Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signaturesPLoS Medicine, 2019
- Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adultsEmergencias, 2019
- Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of InfectionClinical Microbiology Reviews, 2018
- Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy studyThe Lancet Infectious Diseases, 2017